Isofol appoints Gustaf Albèrt as Chief Financial Officer
Isofol Medical AB (publ) has recruited Gustaf Albèrt as Chief Financial Officer. With extensive experience from leading financial positions, Albèrt will strenghten Isofol Medical’s management team in the execution of the company’s development program of the drug candidate Modufolin®.Isofol Medical AB (publ), a clinical stage oncology company, announces the appointment of Gustaf Albèrt as CFO effective as of the 1st of November. Gustaf Albèrt will have an important role in the continued development of Isofol focusing on the pivotal trial ISO-CC-007 where the company’s drug candidate